Adaptive Biotechnologies
ADPT
$2.76
Share price
5.96%
Change (1 day)
-61.41%
Change (1 year)
Categories
Adaptive Biotechnologies (ADPT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.35 B
According to Adaptive Biotechnologies 's latest financial reports the company's total liabilities are $0.35 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Adaptive Biotechnologies - Total liabilities on balance sheet (from 2018 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.35 B | -10.1% |
| 2022-12-31 | $0.39 B | 22.95% |
| 2021-12-31 | $0.31 B | -14.45% |
| 2020-12-31 | $0.37 B | 9.34% |
| 2019-12-31 | $0.34 B | -42.24% |
| 2018-12-31 | $0.59 B | 0.63% |
| 2017-12-31 | $0.58 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 HCA Healthcare HCA | $55.15 B | 15,529.89% | 🇺🇸 USA |
 Premier PINC | $1.44 B | 308.76% | 🇺🇸 USA |
 Community Health Systems
CYH | $15.27 B | 4,230.09% | 🇺🇸 USA |
 Select Medical Holdings SEM | $6.11 B | 1,633.18% | 🇺🇸 USA |